LMLucas E. Matthyssens

Lucas E. Matthyssens

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lucas E. Matthyssens has a total of 129 co-authors. Here are the top co-authors by number of shared publications:

  • Dominique Valteau-Couanet

    Institut Gustave Roussy, Villejuif, Paris, France

    2 shared publications
  • Jakob Stenman

    Karolinska University Hospital, Stockholm, Sweden

    2 shared publications
  • Keith Holmes

    Paediatric Surgery, St George’s Hospital London and Royal Marsden Hospital, Sutton, United Kingdom

    2 shared publications
  • Paul Philippe

    Department of Pediatric Surgery, Pediatric Clinic, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg

    2 shared publications
  • Roly Squire

    Paediatric Oncology, Leeds Teaching Hospital, Leeds, United Kingdom

    2 shared publications
  • Sabine Irtan

    Sorbonne University, Department of Visceral and Neonatal Pediatric Surgery, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France

    2 shared publications

Latest Publications

  • Open Access

    Core Indicator Set for Measuring Quality of Care in Necrotising Enterocolitis: A European Delphi Study

    by Otis C. van Varsseveld, Irene de Haro Jorge, Daniel Rossi, Marlinde van der Kamp, Mohamed Riadh Boukhris, Miriam Duci, Johannes W. Duess, Simon Eaton, Elisabeth M. W. Kooi, Martin Lacher, et al.

    Aim: Inconsistent guidelines and practice variations in necrotising enterocolitis (NEC) hamper care improvements. A universally accepted quality indicator set is needed to standardise and improve care throughout Europe. We aimed to establish a core set relevant to NEC patients and experts. Methods: Clinicians, researchers, and patient representatives evaluated 27 baseline patient characteristics and 41 quality indicators identified by a literature review. Items were rated on a nine‐point Likert scale during three online Delphi survey rounds, followed by a consensus meeting. Results: From 19 European countries, 113 participants completed all Delphi rounds, including five patient representatives. All stakeholders reached consensus on eight baseline characteristics. Among the indicators that reached consensus, five of the top 10 were mutually prioritised by patients and experts. In the consensus meeting, attended by two patient representatives and 49 experts from 16 countries, four additional indicators were included. The final core set comprised eight baseline characteristics and nine indicators: one healthcare structure, three care process and five outcome indicators. Conclusion: This study established nine core quality indicators for NEC treatment through consensus among clinicians, researchers, and patient representatives. Their implementation in European clinical audits supports inter‐institutional benchmarking, ultimately enhancing care and outcomes for infants with NEC.


  • Open Access

    Laparoscopic‐assisted ‘pull‐introducer technique’ for gastrostomy tube placement in small infants: A single‐centre experience

    by Saskia Vande Velde, Stephanie Van Biervliet, Ann J. M. Van Gils, Pauline De Bruyne, Ruth De Bruyne, Lucas Matthyssens, Dirk Van de Putte, Katrien Van Renterghem

    Kirberg et al. described in 2016 a one‐step gastrostomy tube placement, the ‘pull‐introducer’ technique, designed for small‐for‐gestational‐age neonates, combining two endoscopic techniques. Nine infants (weight 3.4–8.1 kg) in our centre required a gastrostomy placement (two infants) or a combined gastrostomy placement and Nissen fundoplication (seven infants). A single‐stage balloon gastrostomy was preferred in all cases because of a significant anaesthetic risk. The pull‐introducer method was chosen because the commercially available one‐step balloon gastrostomy gastropexy devices were considered too large. There were no immediate or long‐term complications (except local infection). All nine infants were discharged from the hospital as planned. After 6 months, the balloon gastrostomy tube was replaced with a balloon button or balloon gastrostomy tube.

  • Top Cited Papers

    Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study

    by Keith Holmes, Ulrike Pötschger, Andrew D. J. Pearson, Sabine Sarnacki, Giovanni Cecchetto, Javier Gomez-Chacon, Roly Squire, Enrique Freud, Adam Bysiek, Lucas E. Matthyssens, et al.

    PURPOSE: To evaluate the impact of surgeon-assessed extent of primary tumor resection on local progression and survival in patients in the International Society of Pediatric Oncology Europe Neuroblastoma Group High-Risk Neuroblastoma 1 trial. PATIENTS AND METHODS: Patients recruited between 2002 and 2015 with stage 4 disease > 1 year or stage 4/4S with MYCN amplification < 1 year who had completed induction without progression, achieved response criteria for high-dose therapy (HDT), and had no resection before induction were included. Data were collected on the extent of primary tumor excision, severe operative complications, and outcome. RESULTS: A total of 1,531 patients were included (median observation time, 6.1 years). Surgeon-assessed extent of resection included complete macroscopic excision (CME) in 1,172 patients (77%) and incomplete macroscopic resection (IME) in 359 (23%). Surgical mortality was 7 (0.46%) of 1,531. Severe operative complications occurred in 142 patients (9.7%), and nephrectomy was performed in 124 (8.8%). Five-year event-free survival (EFS) ± SE (0.40 ± 0.01) and overall survival (OS; 0.45 ± 0.02) were significantly higher with CME compared with IME (5-year EFS, 0.33 ± 0.03; 5-year OS, 0.37 ± 0.03; P < .001 and P = .004). The cumulative incidence of local progression (CILP) was significantly lower after CME (0.17 ± 0.01) compared with IME (0.30 ± 0.02; P < .001). With immunotherapy, outcomes were still superior with CME versus IME (5-year EFS, 0.47 ± 0.02 v 0.39 ± 0.04; P = .038); CILP was 0.14 ± 0.01 after CME and 0.27 ± 0.03 after IME ( P < .002). A hazard ratio of 1.3 for EFS associated with IME compared with CME was observed before and after the introduction of immunotherapy ( P = .030 and P = .038). CONCLUSION: In patients with stage 4 high-risk neuroblastoma who have responded to induction therapy, CME of the primary tumor is associated with improved survival and local control after HDT, local radiotherapy (21 Gy), and immunotherapy.


  • A Novel Standard for Systematic Reporting of Neuroblastoma Surgery: The International Neuroblastoma Surgical Report Form (INSRF)

    by Lucas E. Md Matthyssens, Jed G. Nuchtern, Cees P. Van De Ven, Hany O. S. Md Gabra, Kristin Bjornland, Sabine Irtan, Jakob Stenman, Luca Pio, Kate M. Cross, Stefano Avanzini, et al.

    Objective: To create the first structured surgical report form for NBL with international consensus, to permit standardized documentation of all NBL-related surgical procedures and their outcomes. Summary of Background Data: NBL, the most common extracranial solid malignant tumor in children, covers a wide spectrum of tumors with significant differences in anatomical localization, organ or vessel involvement, and tumor biology. Complete surgical resection of the primary tumor is an important part of NBL treatment, but maybe hazardous, prone to complications and its role in high-risk disease remains debated. Various surgical guidelines exist within the protocols of the different cooperative groups, although there is no standardized operative report form to document the surgical treatment of NBL. Methods: After analyzing the treatment protocols of the SIOP Europe International Neuroblastoma Study Group, Children's Oncology Group, and Gesellschaft fuer Paediatrische Onkologie und Haematologie – German Association of Pediatric Oncology and Haematology pediatric cooperative groups, important variables were defined to completely describe surgical biopsy and resection of NBL and their outcomes. All variables were discussed within the Surgical Committees of SIOP Europe International Neuroblastoma Study Group, Children's Oncology Group, and Gesellschaft fuer Paediatrische Onkologie und Haematologie – German Association of Pediatric Oncology and Haematology. Thereafter, joint meetings were organized to obtain intercontinental consensus. Results: The “International Neuroblastoma Surgical Report Form” provides a structured reporting tool for all NBL surgery, in every anatomical region, documenting all Image Defined Risk Factors and structures involved, with obligatory reporting of intraoperative and 30 day-postoperative complications. Conclusion: The International Neuroblastoma Surgical Report Form is the first universal form for the structured and uniform reporting of NBL-related surgical procedures and their outcomes, aiming to facilitate the postoperative communication, treatment planning and analysis of surgical treatment of NBL.


  • A pilot study of the effectiveness of a serious game CliniPup® on perioperative anxiety and pain in children

    by Lucas E. Matthyssens, Amber Vanhulle, Lara Seldenslach, Geert Vander Stichele, Marc Coppens, Eline Van Hoecke


    • 25 January 2018
      • Vol. 80  (1) , 67-70

    Rectal red blood loss in a healthy toddler is not always a juvenile polyp.

    by T Rousseff, Lucas Matthyssens, K Van Renterghem, D Van De Putte, D De Wulf, M Van Winckel, S Van De Velde, R De Bruyne, Stephanie Van Biervliet

    Aim Heterotopic gastric mucosa is a well-known congenital anomaly in Meckel's diverticula and duplication cysts. Solitary heterotopic gastric mucosa in the rectum is a rare and frequently overlooked abnormality. Starting from a patient history, the literature is searched and all cases reported over the past 20 years are reviewed and compared to a summary of the older cases. Differences between adult and childhood presentation are outlined and our patient is compared with prior reported cases. Case A 3-year-old girl presented with recurrent rectal blood loss caused by heterotopic gastric mucosa without duplication cyst. She was endoscopically treated with two-stage endoscopic surgical dissection (ESD). Up to now, rectal heterotopic gastric mucosa has been reported in 34 adults and 24 children, including this patient. There is an overall male dominance (69%). Presenting complaints in children were recurrent fresh blood loss per anum (96%), pain (46%), perineal ulcers (25%), diarrhoea (8%) and one patient had an ano-cutaneous fistula. Endoscopy revealed a mucosal elevation with a slightly different aspect (33%), a polyp (42%) and a solitary ulcer (25%). Endoscopy in adults reveals more frequently polyps compared to children. Treatment in childhood is mainly surgical where adults are more frequently treated with endoscopic techniques. Conclusion In a child with recurrent rectal bleeding in good general health, it is important to withhold heterotopic gastric mucosa in the differential diagnosis and take sufficient biopsies during endoscopy.


  • Multicentre survey on the current surgical management of oesophageal atresia in Belgium and Luxembourg

    by Helena Reusens, Lucas Matthyssens, Charlotte Vercauteren, Katrien van Renterghem


  • Laparoscopic Treatment of Intestinal Malrotation in Children

    by Nina Ooms, Lucas E. M. Matthyssens, Jos Mth Draaisma, Marc H. W. A. Wijnen, Ivo de Blaauw

    Purpose Intestinal malrotation is a congenital intestinal rotation anomaly, which can be treated by either laparotomy or laparoscopy. Our hypothesis is that laparoscopic treatment leads to less small bowel obstruction because of the fewer adhesions in comparison to laparotomy, without increasing the risk of recurrent volvulus. We analyzed the outcome of patients who had a correction for intestinal malrotation after the introduction of laparoscopy. Methods All patients between 0 and 18 years who underwent a surgical procedure for malrotation in the Radboudumc Amalia Children's Hospital, Nijmegen, the Netherlands, between January 2004 and December 2011 were retrospectively reviewed for duration of operation, perioperative complications, length of hospital stay, and rate of redo surgery for intestinal volvulus or obstruction. Results A total of 83 patients were included of which 33 had a laparoscopic procedure and 50 had a laparotomy for suspected malrotation. Operating time was 63 minutes for the laparoscopic procedure versus 76 minutes for laparotomy (p = 0.588). Significantly more complications were found in the laparotomy group (11 vs. 35%, p = 0.047). However, one patient (aged 4 months) in the laparoscopy group developed an early (< 24 hours) recurrent volvulus. Length of hospital stay was significantly longer after a laparotomy (9 vs. 16 days, p = 0.002). Three (17%) patients in the laparoscopy group needed redo surgery compared with six (9%) in the laparotomy group (p = 0.400). No late volvulus occurred in both groups. After laparotomy, redo surgery because of the small bowel obstruction was more frequent (5 vs. 0%), although this was not statistically significant. Conclusion In both the laparoscopy and laparotomy group, no cases of long-term recurrent volvulus were seen. After laparotomy, more patients developed a late small bowel obstruction because of the adhesions for which redo surgery was needed. In the laparotomy group, the number of complications was significantly higher and the length of hospital stay was significantly longer. Comparing laparoscopy and laparotomy for the treatment of malrotation, no difference exists for the long-term risk of recurrent volvulus. In children aged 6 months or older with suspicion of intestinal malrotation but not presenting with an acute abdomen or hemodynamically instability, laparoscopy should be considered as a first approach to diagnose and subsequently treat intestinal malrotation.


  • Open Access

    Retroperitoneal Liposarcoma: Current Insights in Diagnosis and Treatment

    by Lucas E. Matthyssens, David Creytens, Wim P. Ceelen

    Retroperitoneal liposarcoma (RLS) are rare, biologically heterogeneous tumors that present considerable challenges due to their size and deep location. As a consequence, the majority of patients with high grade RLS will develop locally recurrent disease following surgery, and this constitutes the cause of death in most patients. Here, we review current insights and controversies regarding histology, molecular biology, extent of surgery, (neo)adjuvant treatment, and systemic treatment including novel targeted agents in RLS.